Literature DB >> 16285956

Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum.

Christopher M Dekaney1, Jose M Rodriguez, M Colleen Graul, Susan J Henning.   

Abstract

BACKGROUND & AIMS: Although there have been many recent advances regarding the biology of intestinal stem cells, the field has been hampered significantly by the lack of a method to isolate these cells. Therefore, the aim of this study was to explore the hypothesis that viable intestinal stem cells can be isolated as a side population (SP) by fluorescence-activated cell sorting after staining with the DNA-binding dye Hoechst 33342.
METHODS: Preparations of individual cells from either whole mucosa or epithelium of mouse jejunum were stained with Hoechst 33342 and propidium iodide and then sorted using fluorescence-activated cell sorting. Cells were characterized using fluorochrome-labeled antibodies to surface markers, intracellular markers, and annexin V to detect early apoptosis. Total RNA was isolated from sorted fractions and used for quantitative real-time reverse-transcription polymerase chain reaction to evaluate the expression of cell lineage markers and the intestinal stem-cell marker, Musashi-1.
RESULTS: Adult and neonatal jejunum contain a viable population of cells that shows the SP phenotype and is sensitive to verapamil. This population of cells (from both mucosal and epithelial preparations) includes a CD45-negative fraction corresponding to nonhematopoietic cells, which shows minimal expression of surface markers typically found on stem cells from other tissues and of intracellular markers found in mesenchymal cells. Additionally, these cells were enriched for Musashi-1 and beta1-integrin, were cytokeratin positive, and survived in culture for up to 14 days.
CONCLUSIONS: The CD45-negative SP fraction, although not pure, represents the successful isolation of a viable population significantly enriched in small intestinal epithelial stem cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285956     DOI: 10.1053/j.gastro.2005.08.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  51 in total

1.  Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.

Authors:  Goo Lee; Tatiana Goretsky; Elizabeth Managlia; Ramanarao Dirisina; Ajay Pal Singh; Jeffrey B Brown; Randal May; Guang-Yu Yang; Josette William Ragheb; B Mark Evers; Christopher R Weber; Jerrold R Turner; Xi C He; Rebecca B Katzman; Linheng Li; Terrence A Barrett
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

2.  Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells.

Authors:  Richard J von Furstenberg; Ajay S Gulati; Anand Baxi; Jason M Doherty; Thaddeus S Stappenbeck; Adam D Gracz; Scott T Magness; Susan J Henning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

3.  Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts.

Authors:  S Samuel; R Walsh; J Webb; A Robins; C Potten; Y R Mahida
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-10       Impact factor: 4.249

Review 4.  Small intestinal stem cell markers.

Authors:  Robert K Montgomery; David T Breault
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

Review 5.  Intestinal epithelial cells in vitro.

Authors:  Dharam P Chopra; Alan A Dombkowski; Paul M Stemmer; Graham C Parker
Journal:  Stem Cells Dev       Date:  2010-01       Impact factor: 3.272

6.  Sox9 expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro.

Authors:  Adam D Gracz; Sendhilnathan Ramalingam; Scott T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-25       Impact factor: 4.052

7.  Intestinal stem cells and stem cell-based therapy for intestinal diseases.

Authors:  Mahmoud Shaaban Mohamed; Yun Chen; Chao-Ling Yao
Journal:  Cytotechnology       Date:  2014-07-01       Impact factor: 2.058

8.  Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Satish Ramalingam; Dharmalingam Subramaniam; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

9.  Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury.

Authors:  Robert J George; Mark A Sturmoski; Randal May; Sripathi M Sureban; Brian K Dieckgraefe; Shrikant Anant; Courtney W Houchen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

10.  Cancer stem cells in solid tumors: elusive or illusive?

Authors:  Yvonne Welte; James Adjaye; Hans R Lehrach; Christian Ra Regenbrecht
Journal:  Cell Commun Signal       Date:  2010-05-11       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.